The Kable – A curated weekday newsletter for professionals in the life sciences sectors

Features

Kenya: Crises and Opportunities in Human and Environmental Health

By Ria Purandare | February 24, 2023

One Health: Healthcare Transformations in Indonesia

By Ria Purandare | February 1, 2023

View all

Aasif Khan

CEO, G7 Universal

Every C-suite executive in the pharma and biotech industry should be reading The Kable for incisive business intelligence.

Ram Gulwady

Technology Adviser

The Kable is a kaleidoscopic view of the pharma world. Immensely useful for the serious news digger.

Sudhir Kant

Consultant

The format is very digestible.
In minutes I have the day summed
up.

Amer Almalakh

Executive Lead

The Kable is a new out-of-the-box phenomenon of information sharing that has added value for the pharma industry. The Kable is changing the mindset towards creativity and thinking agility.

Rushin Shah

Head of Marketing

I was hooked from day 1. The Kable has become essential to my daily ritual as I get a quick download of industry insights quickly and conveniently. Everyone keeps asking where I get these tips from. Now they know.

Moosa Areff

COO, Kiara Health

The Kable is a holistic view of the global pharma industry and has alerted us to new opportunities and trends. The news is relevant, up to date and condensed in a quick-read format that is delivered to my inbox daily.

Saroja Chandan

Executive Director, Fabtech

There is no better gift than timely business intelligence, and The Kable is your daily dose. Our customers are completely into it.

Sundhar C K

COO, Steriscience Specialties

Amazed at the intelligence of The Kable. Information sharing is so fast that even existing pharma media who at one point of time claimed they are fastest are no match.

Sami Mahbub

Dy Manager, Synovia Pharma

I'm constantly looking to learn, inform myself and be updated on current pharma news. The Kable gives me every single important update about the pharma world.